Global Locations
Leveraging our presence across multiple countries to provide efficient solutions
With our operations across the USA, India, and Mexico, we offer comprehensive, flexible, and cost-efficient solutions to our Sponsors.
Explore our Global Locations
India
AXIS India was established in 2004, providing expert and innovative clinical research solutions to pharmaceutical companies across the world. We have conducted more than 3,500 studies for submission in US, Europe, Brazil, Russia, India, Australia, South Korea, South Africa, GCC.
Our team of more than 500 people includes highly trained clinical research professionals, project managers, and skilled bioanalytical scientists. With dedicated PK/Statistics and Clinical Data Management teams, the company offers end-to-end solutions to customers.
For Bioequivalence studies, AXIS India has 2 CPUs with more than 330 beds and 26 of the latest LC-MS/MS systems. We have conducted more than 50 clinical endpoint studies in patients across therapeutic areas including oncology, CNS, gastroenterology, dermatology, ophthalmology, respiratory, and more.
AXIS India has built unique expertise in Biosimilars, conducting a number of Phase III biosimilar clinical trials.
Mexico
AXIS Latina started operations in 2011 and has conducted more than 400 studies in the last 10 years. With a team of 70+ people in Mexico, we cater to the clinical development needs of major domestic and international pharmaceutical companies for registration of their products in Mexico and other Latin American countries. Besides COFEPRIS, we are recognized by ISP Chile for Bioequivalence studies. AXIS Latina has 2 CPUs spread across 40,00 sq ft with 130 beds and 4 of the latest LC-MS/MS systems.
AXIS Latina is the only CRO approved for studies in controlled substances in Mexico.
